Hodgkin lymphoma accounts for less than 1% of all cancers in the UK (2013).[1-4]
In 2013, there were 1,954 new cases of Hodgkin lymphoma in the UK: 1,100 (56%) in males and 854 (44%) in females, giving a male:female ratio of around 13:10.[1-4] The
Hodgkin Lymphoma (C81), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2013
|AS Rate - 95% LCL||3.3||2.7||3.1||3.9||3.4|
|AS Rate - 95% UCL||3.8||4.7||4.6||7.2||3.8|
|AS Rate - 95% LCL||2.5||1.3||1.9||1.8||2.5|
|AS Rate - 95% UCL||2.9||2.7||3.1||4.1||2.8|
|AS Rate - 95% LCL||2.9||2.2||2.6||3.2||3.0|
|AS Rate - 95% UCL||3.2||3.4||3.6||5.1||3.2|
95% LCL and 95% UCL are the 95% lower and upper
ASR calculated with ESP2013. Not comparable with ASRs calculated with ESP1976.
Although there is variation in Hodgkin lymphoma incidence across the UK [6,7] this variation appears to be mostly artefactual, reflecting differences in registration methods, diagnosis and classification.
- Data were provided by the Office for National Statistics on request, July 2015. Similar data can be found here: http://www.ons.gov.uk/ons/rel/vsob1/cancer-statistics-registrations--england--series-mb1-/index.html.
- Data were provided by ISD Scotland on request, April 2015. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
- Data were provided by the Welsh Cancer Intelligence and Surveillance Unit on request, February 2015. Similar data can be found here: http://www.wales.nhs.uk/sites3/page.cfm?orgid=242&pid=59080.
- Data were provided by the Northern Ireland Cancer Registry on request, March 2015. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
- NCIN. Cancer Incidence and Mortality by Cancer Network, UK, 2005. London: NCIN; 2008
- NCIN. Data on haematological cancers by cancer network, England, 2001-2008 – Atlas (Accessed January 2014
- Haematological Malignancy Research Network. Haematological malignancies & cancer registration in England (2004-2008). Quality appraisal comparing data from the National Cancer Data Repository (NCDR) with the population-based Haematological Malignancy Research Network (HMRN). Final Report. London: Leukaemia & Lymphoma Research; 2012